Table 3.

Value creation of a drug traceability system.

Expected Values	Lovis (2008) [39]	Alfaro & Rábade (2009) [23]	Canavari et al. (2010) [37]	Dabbene, Gay e Tortia (2014) [36]	Epelbaum e Martinez (2014) [40]	Narsimhalu, Potdar e Kaur (2015) [41]	Theyel (2017) [7]
Increased Supply Chain Efficiency	√				√	√
Preventing errors/Reliability/improves accuracy	√	√			√	√	√
Protect public health. (Avoid Fraud and Falsification)	√				√		√
Allow medical-legal investigations	√
Clinical research and epidemiological surveillance	√
Improve flow and process management	√	√	√	√	√		√
Increased Profit/Cost/Loss Reduction/Inventory Optimization		√				√	√
Employee Satisfaction/Shared Value			√				√
Fraud Prevention Measures/Patient Safety/	√			√
Improvement in quality				√	√	√
Reputation/Brand					√
Innovation							√
Flexibility
Differentiation of products/competitive advantage		√			√